Satellos Bioscience Inc. Common Stock (MSLE) Live Share Price, Invest From India

Satellos Bioscience Inc. Common Stock Stock Performance

as on May 13, 2026 at 6:56 am IST

Day's Low
Day's High
$7.16
Day's Price Range
$7.52
$7.41
3.37%
Downside
1.48%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$7.41
100.00%
Downside
-100.00%
Upside

Satellos Bioscience Inc. Common Stock share price movements today

Previous Close: $7.30
Open: $7.52
Volume: 387.0K
Day's Low - High: $7.16 - $7.52

Satellos Bioscience Inc. Common Stock Historical Returns

1 Month Return: + 12.31 %
3 Month Return: -35.23 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Satellos Bioscience Inc. Common Stock Stock Fundamentals & Key Indicators

Check Satellos Bioscience Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$160.2M

EPS (TTM)

-3

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-66.37%

Satellos Bioscience Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Satellos Bioscience Inc. Common Stock with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Satellos Bioscience Inc. Common Stock	NA	$160.2M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$39.4B	113.59%	74.13	12.55%
BeiGene, Ltd.	NA	$32.2B	NA	70.46	8.94%
Vertex Pharmaceuticals Inc	BUY	$109.1B	104.61%	25.51	35.51%
Regeneron Pharmaceuticals Inc	BUY	$74.9B	40.55%	17.45	29.65%

Indian Investors' Interest in Satellos Bioscience Inc. Common Stock Stock

Search interest for Satellos Bioscience Inc. Common Stock Stock has increased by 17% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 13, 2026 to May 13, 2026

Change:17% versus previous 30 day period

Satellos Bioscience Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Income	-3	-4	-6	-6	-5	-7
EBITDA	-3	-3	-6	-6	-5	-
Interest Expense	-	-	-	-	-	-
Depreciation	0	0	0	-	0	-
Income Before Tax	-6	-3	-6	-5	-5	-7
Income Tax Expense	-	-	0	0	0	-
Net Income	-6	-2	-6	-5	-5	-7
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Satellos Bioscience Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-
Gross Profit	0	-	-	-	-
Operating Income	-3	-6	-11	-19	-26
EBITDA	-11	-8	-11	-19	-
Interest Expense	0	-	0	-	-
Depreciation	0	0	0	0	0
Income Before Tax	-12	-8	-11	-19	-24
Income Tax Expense	-	0	-	-	-
Net Income	-9	-8	-8	-13	-24
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%

Satellos Bioscience Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-3	-6	-5	-5	-7
Operating Cash Flow	-4	-7	-4	-4	-7
Investing Cash Flow	-8	-	8	-15	-
Financing Cash Flow	37	0	1	0	0
Change in Cash	22	-7	5	-18	-9

Satellos Bioscience Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-8	-11	-19	-24
Operating Cash Flow	-4	-8	-17	-23
Investing Cash Flow	0	-13	4	-
Financing Cash Flow	2	38	37	2
Change in Cash	-2	15	24	-30

Insights on Satellos Bioscience Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NEGATIVE IMPACT
Price Dip
In the last 3 months, MSLE stock has moved down by -36.5%

About Satellos Bioscience Inc. Common Stock

Satellos Bioscience Inc., a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia. The company uses its proprietary discovery platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247, an oral, small molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a license agreement the with Ottawa Hospital Research Institute (OHRI); and an option agreement with the University of British Columbia. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.

Organisation	Satellos Bioscience Inc. Common Stock
Headquarters	Royal Bank Plaza, Toronto, ON, Canada, M5J 2J1
Industry	Biotechnology
CEO	Mr. Francis Gleeson B.B.A. M.B.A
E-voting on shares	Click here to vote

Key Management of Satellos Bioscience Inc. Common Stock

Name	Title
Dr. Philip Lambert M.A., Ph.D.	Chief Scientific Officer
Dr. Michael A. Rudnicki Ph.D.	Co-Founder & Chief Discovery Officer
Mr. Michael Liggett B.Sc., Bsc. Pharm., C.A., C.P.A.	Strategic Advisor
Mr. Warren Whitehead C.M.A., CPA	Head of Corporate Strategy
Mr. Francis Gleeson B.B.A. M.B.A	Co-Founder, CEO, President & Director
Ms. Elizabeth Williams C.A., CPA	CFO & Corporate Secretary
Mr. J. Robert Hall CFA	Senior Vice President of Finance & Administration
Dr. Ryan Mitchell Ph.D.	Senior VP & Head of Corporate Development
Ms. Desiree Chan	Chief of Staff
Dr. Wildon Farwell M.D., M.P.H.	Chief Medical Officer

FAQs

What is Satellos Bioscience Inc. Common Stock share price today?

Satellos Bioscience Inc. Common Stock share price today is $7.41 as on May 13, 2026 at 1:26 am IST at the close of the market. Satellos Bioscience Inc. Common Stock share today touched a day high of $7.52 and a low of $7.16.

What is the 52 week high and 52 week low for Satellos Bioscience Inc. Common Stock share?

Satellos Bioscience Inc. Common Stock share touched a 52 week high of $ on January 1, 1970 and a 52 week low of $ on January 1, 1970. Satellos Bioscience Inc. Common Stock stock price today i.e. May 13, 2026 at 1:26 am IST is closed at $7.41,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Satellos Bioscience Inc. Common Stock's market capitalisation today?

Satellos Bioscience Inc. Common Stock market capitalisation is $0.00T as on May 13, 2026 at 1:26 am IST.

How to invest in Satellos Bioscience Inc. Common Stock Stock (MSLE) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Satellos Bioscience Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Satellos Bioscience Inc. Common Stock Shares that will get you 0.2024 shares as per Satellos Bioscience Inc. Common Stock share price of $7.41 per share as on May 13, 2026 at 1:26 am IST.

What is the minimum amount required to buy Satellos Bioscience Inc. Common Stock Stock (MSLE) from India?

Indian investors can start investing in Satellos Bioscience Inc. Common Stock (MSLE) shares with as little as ₹95.618 or $1 (as of May 13, 2026 at 6:42 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹956.18 in Satellos Bioscience Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on May 13, 2026 at 6:42 am IST). Based on Satellos Bioscience Inc. Common Stock share’s latest price of $7.41 as on May 13, 2026 at 1:26 am IST, you will get 1.3495 shares of Satellos Bioscience Inc. Common Stock. Learn more about fractional shares .